That translates to approximately 4 fewer heart attacks, strokes, or cardiovascular deaths per 100 people over 3 years
Wegovy and other semaglutide medications have experienced periods of limited availability, making it difficult for some patients to obtain their prescriptions.[5] During the height of the shortages, healthcare providers sometimes had to adjust dosing strategies to help patients maintain treatment.[6] Novo Nordisk, the manufacturer of Wegovy and Ozempic, has reported efforts to increase production and improve supply, though demand may still exceed availability in some areas.[7] Compounded semaglutide may be more readily available in some cases and may be less expensive for certain patients
If you landed here researching the capsule version, you'll want a different review
"We have seen our a1c's lowered drastically patients have gotten healthier so I think it's a great thing." GLP-1S cover a wide range of medication
Optimizing GLP1 hormone production through the lens of the gut microbiome
Adjust proportionally if your therapeutic dose is lower